Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure

American Journal of Cardiology

Volumn 106, Issue 5, 2010, Pages 694-700

  Kazory, Amir ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ARGIPRESSIN; BIOLOGICAL MARKER; CREATININE; RENIN; UREA; NEUROPEPTIDE;

ADRENERGIC SYSTEM; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; FLUID BALANCE; HEART FAILURE; HUMAN; KIDNEY FUNCTION; NEUROENDOCRINOLOGY; PATHOPHYSIOLOGY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; UREA NITROGEN BLOOD LEVEL; BLOOD; PHYSIOLOGY; PREDICTIVE VALUE;

BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATININE; HEART FAILURE; HUMANS; NEUROPEPTIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 77955920246     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.024     Document Type: Review

References (42)

1. R.W. Schrier, and W.T. Abraham Hormones and hemodynamics in heart failure N Engl J Med 341 1999 577 585
2. D.S. Lee, P.C. Austin, J.L. Rouleau, P.P. Liu, D. Naimark, and J.V. Tu Predeicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
3. G.C. Fonarow, K.F. Adams Jr, W.T. Abraham, C.W. Yancy, W.J. Boscardin ADHERE Scientific Advisory Committee, Study Group, and Investigators Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580 (Pubitemid 40171239)
4. G.M. Felker, J.D. Leimberger, R.M. Califf, M.S. Cuffe, B.M. Massie, K.F. Adams Jr, M. Gheorghiade, and C.M. O'Connor Risk stratification after hospitalization for decompensated heart failure J Card Fail 10 2004 460 466
5. R.A. Fenton, and M.A. Knepper Urea and renal function in the 21st century: insights from knockout mice J Am Soc Nephrol 18 2007 679 688
6. R.A. Fenton Essential role of vasopressin-regulated urea transport processes in the mammalian kidney Pflugers Arch 458 2009 169 177
7. C.L. Chou, and M.A. Knepper Inhibition of urea transport in inner medullary collecting duct by phloretin and urea analogues Am J Physiol 257 1989 F359 F365
8. J.M. Sands Renal urea transporters Curr Opin Nephrol Hypertens 13 2004 525 532
9. R.W. Schrier Blood urea nitrogen and serum creatinine: not married in heart failure Circ Heart Fail 1 2008 2 5
10. Y.C. Chen, M.A. Cadnapaphornchai, and R.W. Schrier Clinical update on renal aquaporins Biol Cell 97 2005 357 371
11. S. Nielsen, S.R. DiGiovanni, E.I. Christensen, M.A. Knepper, and H.W. Harris Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney Proc Natl Acad Sci U S A 90 1993 11663 11667
12. J.B. Wade, S. Nielsen, R.A. Coleman, and M.A. Knepper Long-term regulation of collecting duct water permeability: freeze-fracture analysis of isolated perfused tubules Am J Physiol 266 1994 F723F230
13. P.H. Baylis Osmoregulation and control of vasopressin secretion in healthy humans Am J Physiol 253 1987 R671 R678
14. B. Mettauer, J.L. Rouleau, D. Bichet, C. Juneau, C. Kortas, J.N. Barjon, and J. de Champlain Sodium and water excretion abnormalities in congestive heart failure Determinant factors and clinical implications Ann Intern Med 105 1986 161 167
15. P. Bie, N.H. Secher, A. Astrup, and J. Warberg Cardiovascular and endocrine responses to head-up tilt and vasopressin infusion in humans Am J Physiol 251 1986 R735 R741
16. D.L. Xu, P.Y. Martin, M. Ohara, J. St. John, T. Pattison, X. Meng, K. Morris, J.K. Kim, and R.W. Schrier Upregulation of aquaporin-2 water channel expression in chronic heart failure rat J Clin Invest 99 1997 1500 1505
17. M.G. Nicholls, J.I. Robertson, and T. Inagami The renin-angiotensin system in the twenty-first century Blood Press 10 2001 327 343
18. L.M. Harrison-Bernard The renal renin-angiotensin system Adv Physiol Educ 33 2009 270 274
19. G.F. DiBona Physiology in perspective: the wisdom of the body Neural control of the kidney Am J Physiol Regul Integr Comp Physiol 289 2005 R633 R641
20. R.W. Schrier Body fluid volume regulation in health and disease: a unifying hypothesis Ann Intern Med 113 1990 155 159
21. S.K. Kumar, and P.J. Mather AVP receptor antagonists in patients with CHF Heart Fail Rev 14 2009 83 86
22. G.S. Francis, C. Benedict, D.E. Johnstone, P.C. Kirlin, J. Nicklas, C.S. Liang, S.H. Kubo, E. Rudin-Toretsky, and S. Yusuf Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure A substudy of the Studies of Left Ventricular Dysfunction (SOLVD) Circulation 82 1990 1724 1729
23. C.R. Benedict, D.E. Johnstone, D.H. Weiner, M.G. Bourassa, V. Bittner, R. Kay, P. Kirlin, B. Greenberg, R.M. Kohn, J.M. Nicklas SOLVD Investigators Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the registry of Studies of Left Ventricular Dysfunction J Am Coll Cardiol 23 1994 1410 1420
24. T.B. Levine, G.S. Francis, S.R. Goldsmith, A.B. Simon, and J.N. Cohn Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure Am J Cardiol 49 1982 1659 1666
25. J.N. Cohn, T.B. Levine, M.T. Olivari, V. Garberg, D. Lura, G.S. Francis, A.B. Simon, and T. Rector Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
26. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J Am Coll Cardiol 54 2009 1747 1762
27. I.S. Anand, L.D. Fisher, Y.T. Chiang, R. Latini, S. Masson, A.P. Maggioni, R.D. Glazer, G. Tognoni, J.N. Cohn Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 2003 1278 1283
28. A. Sigurdsson, O. Amtorp, T. Gundersen, B. Nilsson, J. Remes, K. Swedberg The Ramipril Trial Study Group Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril Br Heart J 72 1994 422 427 (Pubitemid 24341546)
29. M. Sarraf, A. Masoumi, and R.W. Schrier Cardiorenal syndrome in acute decompensated heart failure Clin J Am Soc Nephrol 4 2009 2013 2026
30. T.D. Smilde, D.J. van Veldhuisen, G. Navis, A.A. Voors, and H.L. Hillege Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction Circulation 114 2006 1572 1580
31. Scrutinio D, Passantino A, Lagioia R, Santoro D, Cacciapaglia E. Detection and prognostic impact of renal dysfunction in patients with chronic heart failure and normal serum creatinine. Int J Cardiol. In press.
32. D. Aronson, M.A. Mittleman, and A.J. Burger Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure Am J Med 116 2004 466 473
33. G. Filippatos, J. Rossi, D.M. Lloyd-Jones, W.G. Stough, J. Ouyang, D.D. Shin, C. O'connor, K.F. Adams, C. Orlandi, and M. Gheorghiade Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study J Card Fail 13 2007 360 364
34. G. Giamouzis, A.P. Kalogeropoulos, V.V. Georgiopoulou, S.A. Agha, M.A. Rashad, S.R. Laskar, A.L. Smith, and J. Butler Incremental value of renal function in risk prediction with the Seattle Heart Failure Model Am Heart J 157 2009 299 305
35. L. Klein, B.M. Massie, J.D. Leimberger, C.M. O'Connor, I.L. Pia, K.F. Adams Jr, R.M. Califf, M. Gheorghiade OPTIME-CHF Investigators Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Circ Heart Fail 1 2008 25 33
36. H.J. Shenkman, W. Zareba, and J.D. Bisognano Comparison of prognostic significance of amino-terminal pro-brain natriuretic peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure Am J Cardiol 99 2007 1143 1145
37. C.A. Cauthen, M.J. Lipinski, A. Abbate, D. Appleton, A. Nusca, A. Varma, E. Goudreau, M.J. Cowley, and G.W. Vetrovec Relation of blood urea nitrogen to long-term mortality in patients with heart failure Am J Cardiol 101 2008 1643 1647
38. R. Kerzner, B.F. Gage, K.E. Freedland, and M.W. Rich Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction Am Heart J 146 2003 286 290
39. J.T. Heywood, W. Elatre, R.G. Pai, S. Fabbri, and B. Huiskes Simple clinical criteria to determine the prognosis of heart failure J Cardiovasc Pharmacol Ther 10 2005 173 180
40. Y. Kinugasa, M. Kato, S. Sugihara, M. Hirai, K. Kotani, K. Ishida, K. Yanagihara, Y. Kato, K. Ogino, O. Igawa, I. Hisatome, and C. Shigemasa A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failurehypoalbuminemia as an additional prognostic factor Circ J 73 2009 2276 2281
41. H.J. Lin, C.L. Chao, K.L. Chien, Y.L. Ho, C.M. Lee, Y.H. Lin, Y.W. Wu, R.B. Hsu, N.K. Chou, S.S. Wang, C.Y. Chen, and M.F. Chen Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure Clin Res Cardiol 98 2009 487 492
42. T.D. Smilde, K. Damman, P. van der Harst, G. Navis, B. Daan Westenbrink, A.A. Voors, F. Boomsma, D.J. van Veldhuisen, and H.L. Hillege Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure Clin Res Cardiol 98 2009 121 129